Exceptionally disappointed in Doug Melton of @HHMI for publishing new important diabetes paper as #closedaccess pic.twitter.com/DefoWwmiBR
— Jonathan Eisen (@phylogenomics) October 10, 2014
With a little more discussion I just got more angry
.@HHMINEWS and publishes the groundbreaking paper behind a paywall so online the elite can see it #closedaccess pic.twitter.com/ZPriyCdHvY
— Jonathan Eisen (@phylogenomics) October 10, 2014
.@David_Dobbs @Stephen_Curry @rpg7twit massive hype yet paywall is a big f#*$ you to those who care about diabetics pic.twitter.com/MErZi5pzL7
— Jonathan Eisen (@phylogenomics) October 11, 2014
@cryptogenomicon @phylogenomics @Stephen_Curry @David_Dobbs @rpg7twit the paper is available at
http://t.co/Rt2el9b9W5
— HHMI NEWS (@HHMINEWS) October 11, 2014
I was angry both about the overselling of the implications of the paper and the fact that the paper was not published in an open manner. This was despite the stated goals of HHMI which funds some of the Melton Lab work.
.@Stephen_Curry @David_Dobbs @rpg7twit only 1/5 pubs on Melton HHMI page http://t.co/L1p2BEKrQ6 is free #closedaccess pic.twitter.com/KQDY5ZLjuA
— Jonathan Eisen (@phylogenomics) October 11, 2014
I was especially upset that much of the press coverage was reporting on an imminent cure for type I diabetes when this was clearly not imminent. Although I note - some coverage was OK. Like these:
... has there been too much hype? NHS cautions that talks of a "cure" for type 1 diabetes are premature http://t.co/MUZiRRWq3F
— Judith Taylor (@Endo_Editor) October 11, 2014
Risks of overhyping science: Telegraph says "Cure for Type 1 diabetes imminent after Harvard stem-cell breakthrough" http://t.co/hwDTHOZgeR
— Jonathan Eisen (@phylogenomics) October 11, 2014
Another good piece of news - HHMI got Doug Melton to post a copy of the paper on a web site
@cryptogenomicon @phylogenomics @Stephen_Curry @David_Dobbs @rpg7twit the paper is available at
http://t.co/Rt2el9b9W5
— HHMI NEWS (@HHMINEWS) October 11, 2014
Although this was kind of hidden
@HHMINEWS @cryptogenomicon @Stephen_Curry @David_Dobbs @rpg7twit tx - is that newly added? can you get link posted w/ all PR/news stories?
— Jonathan Eisen (@phylogenomics) October 11, 2014
@HHMINEWS @cryptogenomicon @Stephen_Curry @David_Dobbs @rpg7twit not linked from http://t.co/PTauxXWosy or http://t.co/8vmUpQVuBf or others
— Jonathan Eisen (@phylogenomics) October 11, 2014
Another good thing - Paul Knoepfler, a colleague of mine at UC Davis wrote a blog post for his excellent STEM cell blog about the Harvard study and the hype.
@phylogenomics @David_Dobbs @Stephen_Curry @rpg7twit If interested, my take on this paper & media hype http://t.co/6glBEGQo1F
— Paul Knoepfler (@pknoepfler) October 11, 2014
Thank you @pknoepfler for reality check on very important but overhyped Diabetes Stem Cell study http://t.co/w443cDOGgb
— Jonathan Eisen (@phylogenomics) October 11, 2014
But the hype was still spreading ...
Risks of overhyping science: Telegraph says "Cure for Type 1 diabetes imminent after Harvard stem-cell breakthrough" http://t.co/hwDTHOZgeR
— Jonathan Eisen (@phylogenomics) October 11, 2014
So I felt like there was a continued need to say something about this
Ultimately @harvard & Doug Melton bear some responsibility for press overhyping their #diabetes stem cell work pic.twitter.com/8hwwmlsWFf
— Jonathan Eisen (@phylogenomics) October 11, 2014
I even changed a talk I was giving on Sunday to include a discussion of this paper and the hype as, well, a bad thingAnd I thought, and kind of hoped, that this might just go away. And then, many people forwarded me this email from Harvard sent out as part of a fundraising campaign. Most of the people who sent it to me sent it in happiness with the possibility of a cure for type 1 diabetes. Here is the email:
"A giant breakthrough in making that possible" with "that" referring to "finding a cure". And then they say "these cells can replace or augment daily insulin injections" without saying that this WAS NOT IN HUMANS. THIS WAS IN MOUSE. $*#($#) DECEPTIVE LYING SCHMUCKS.
And they end this email with "make a gift today." How about this Harvard. I will make donations to anyone but you until you stop marketing in hope and hype and start being responsible.
UPDATE 10/16/14 8 AM PST
Some of the overhyped statements relating to this story:
Harvard Press Story: “We are now just one preclinical step away from the finish line,” said Melton
Rawstory: Stem-cell cure for Type 1 diabetes ‘on par with discovery of antibiotics’
Telegraph: Cure for Type 1 diabetes iminent
Times of India: Type 1 diabetes cure within reach after breakthrough that could spell end of insulin injections for millions
BBC: Giant Leap to Type 1 Diabetes Cure
No comments:
Post a Comment